$SGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Seagen Inc.. Get notifications about new insider transactions in Seagen Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 33 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 8,661 | 103,932 | 147,451 | |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 9,797 | 117,564 | 156,112 | |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 3,926 | 47,112 | 165,909 | |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 900 | 10,800 | 169,835 | |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 100 | 1,200 | 170,735 | |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 105.29 | 200 | 21,058 | 758,784 | 759 K to 758.8 K (-0.03 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 200 | 2,400 | 758,984 | 758.8 K to 759 K (+0.03 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 106.87 | 1,549 | 165,542 | 758,784 | 760.3 K to 758.8 K (-0.20 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 1,549 | 18,588 | 760,333 | 758.8 K to 760.3 K (+0.20 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 107.53 | 953 | 102,476 | 758,784 | 759.7 K to 758.8 K (-0.13 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 953 | 11,436 | 759,737 | 758.8 K to 759.7 K (+0.13 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 108.68 | 2,386 | 259,310 | 758,784 | 761.2 K to 758.8 K (-0.31 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 2,386 | 28,632 | 761,170 | 758.8 K to 761.2 K (+0.31 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 109.75 | 8,661 | 950,545 | 758,784 | 767.4 K to 758.8 K (-1.13 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 8,661 | 103,932 | 767,445 | 758.8 K to 767.4 K (+1.14 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 110.79 | 9,797 | 1,085,410 | 758,784 | 768.6 K to 758.8 K (-1.27 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 9,797 | 117,564 | 768,581 | 758.8 K to 768.6 K (+1.29 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 111.47 | 3,926 | 437,631 | 758,784 | 762.7 K to 758.8 K (-0.51 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 3,926 | 47,112 | 762,710 | 758.8 K to 762.7 K (+0.52 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 112.53 | 900 | 101,277 | 758,784 | 759.7 K to 758.8 K (-0.12 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 900 | 10,800 | 759,684 | 758.8 K to 759.7 K (+0.12 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 113.29 | 100 | 11,329 | 758,784 | 758.9 K to 758.8 K (-0.01 %) |
Mar 11 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 100 | 1,200 | 758,884 | 758.8 K to 758.9 K (+0.01 %) |
Mar 10 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 15.46 | 3,502 | 54,141 | 46,697 | |
Mar 10 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 12.00 | 4,498 | 53,976 | 0 | |
Mar 10 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 116.25 | 200 | 23,250 | 188,674 | 188.9 K to 188.7 K (-0.11 %) |
Mar 10 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 115.16 | 4,298 | 494,958 | 188,874 | 193.2 K to 188.9 K (-2.22 %) |
Mar 10 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 12.00 | 4,498 | 53,976 | 193,172 | 188.7 K to 193.2 K (+2.38 %) |
Mar 10 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 114.53 | 3,502 | 401,084 | 188,674 | 192.2 K to 188.7 K (-1.82 %) |
Mar 10 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 15.46 | 3,502 | 54,141 | 192,176 | 188.7 K to 192.2 K (+1.86 %) |
Feb 20 2020 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 116.33 | 350 | 40,716 | 107,659 | 108 K to 107.7 K (-0.32 %) |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 8,286 | 99,432 | 170,835 | |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 9,939 | 119,268 | 179,121 | |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 5,002 | 60,024 | 189,060 | |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 5,245 | 62,940 | 194,062 | |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 113.39 | 8,286 | 939,550 | 758,784 | 767.1 K to 758.8 K (-1.08 %) |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 8,286 | 99,432 | 767,070 | 758.8 K to 767.1 K (+1.09 %) |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 114.32 | 9,939 | 1,136,226 | 758,784 | 768.7 K to 758.8 K (-1.29 %) |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 9,939 | 119,268 | 768,723 | 758.8 K to 768.7 K (+1.31 %) |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 115.38 | 5,002 | 577,131 | 758,784 | 763.8 K to 758.8 K (-0.65 %) |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 5,002 | 60,024 | 763,786 | 758.8 K to 763.8 K (+0.66 %) |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 116.34 | 5,245 | 610,203 | 758,784 | 764 K to 758.8 K (-0.69 %) |
Feb 12 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 5,245 | 62,940 | 764,029 | 758.8 K to 764 K (+0.69 %) |
Feb 05 2020 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 108.51 | 727 | 78,887 | 108,009 | 108.7 K to 108 K (-0.67 %) |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 27,153 | 325,836 | 199,307 | |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 1,319 | 15,828 | 226,460 | |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 111.28 | 27,153 | 3,021,586 | 758,784 | 785.9 K to 758.8 K (-3.45 %) |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 27,153 | 325,836 | 785,937 | 758.8 K to 785.9 K (+3.58 %) |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 112.09 | 1,319 | 147,847 | 758,784 | 760.1 K to 758.8 K (-0.17 %) |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 1,319 | 15,828 | 760,103 | 758.8 K to 760.1 K (+0.17 %) |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 27,153 | 325,836 | 199,307 | |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 1,319 | 15,828 | 226,460 | |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 111.28 | 27,153 | 3,021,586 | 758,784 | 785.9 K to 758.8 K (-3.45 %) |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 27,153 | 325,836 | 785,937 | 758.8 K to 785.9 K (+3.58 %) |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 112.09 | 1,319 | 147,847 | 758,784 | 760.1 K to 758.8 K (-0.17 %) |
Jan 10 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 1,319 | 15,828 | 760,103 | 758.8 K to 760.1 K (+0.17 %) |
Jan 09 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | M | 12.76 | 17,500 | 223,300 | 0 | |
Jan 09 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Buy | M | 12.76 | 17,500 | 223,300 | 90,263 | 72.8 K to 90.3 K (+24.05 %) |
Dec 23 2019 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Grant | A | 0.00 | 871 | 0 | 158,438 | 157.6 K to 158.4 K (+0.55 %) |
Dec 23 2019 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Grant | A | 0.00 | 871 | 0 | 188,389 | 187.5 K to 188.4 K (+0.46 %) |
Dec 23 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Grant | A | 0.00 | 560 | 0 | 108,611 | 108.1 K to 108.6 K (+0.52 %) |
Dec 23 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Grant | A | 0.00 | 6,905 | 0 | 108,051 | 101.1 K to 108.1 K (+6.83 %) |
Dec 23 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 3,100 | 0 | 758,784 | 755.7 K to 758.8 K (+0.41 %) |
Dec 23 2019 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Afairs | Grant | A | 0.00 | 697 | 0 | 71,385 | 70.7 K to 71.4 K (+0.99 %) |
Dec 23 2019 | SGEN | SEATTLE GENETICS I ... | TAYLOR ROBIN G | Chief Commercial Of ... | Grant | A | 0.00 | 61 | 0 | 33,025 | 33 K to 33 K (+0.19 %) |
Dec 17 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 114.07 | 2,000 | 228,140 | 101,146 | 103.1 K to 101.1 K (-1.94 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 500 | 6,000 | 227,779 | |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 1,800 | 21,600 | 228,279 | |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 2,111 | 25,332 | 230,079 | |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 6,734 | 80,808 | 232,190 | |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 17,327 | 207,924 | 238,924 | |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 117.76 | 500 | 58,880 | 755,684 | 756.2 K to 755.7 K (-0.07 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 500 | 6,000 | 756,184 | 755.7 K to 756.2 K (+0.07 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 116.98 | 1,800 | 210,564 | 755,684 | 757.5 K to 755.7 K (-0.24 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 1,800 | 21,600 | 757,484 | 755.7 K to 757.5 K (+0.24 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 115.53 | 2,111 | 243,884 | 755,684 | 757.8 K to 755.7 K (-0.28 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 2,111 | 25,332 | 757,795 | 755.7 K to 757.8 K (+0.28 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 114.59 | 6,734 | 771,649 | 755,684 | 762.4 K to 755.7 K (-0.88 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 6,734 | 80,808 | 762,418 | 755.7 K to 762.4 K (+0.89 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 114.08 | 17,327 | 1,976,664 | 755,684 | 773 K to 755.7 K (-2.24 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 17,327 | 207,924 | 773,011 | 755.7 K to 773 K (+2.29 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 12.00 | 8,000 | 96,000 | 4,498 | |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 117.61 | 1,049 | 123,373 | 187,518 | 188.6 K to 187.5 K (-0.56 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 117.09 | 6,951 | 813,893 | 188,567 | 195.5 K to 188.6 K (-3.56 %) |
Dec 10 2019 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 12.00 | 8,000 | 96,000 | 195,518 | 187.5 K to 195.5 K (+4.27 %) |
Nov 27 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Option Exercise | M | 65.11 | 5,000 | 325,550 | 33,860 | |
Nov 27 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 121.48 | 5,000 | 607,388 | 103,146 | 108.1 K to 103.1 K (-4.62 %) |
Nov 27 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Buy | M | 65.11 | 5,000 | 325,550 | 108,146 | 103.1 K to 108.1 K (+4.85 %) |
Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 19.02 | 4,942 | 93,997 | 0 | |
Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 19.02 | 12,558 | 238,853 | 4,942 | |
Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Sell | S | 120.46 | 4,942 | 595,313 | 40,168 | 45.1 K to 40.2 K (-10.96 %) |
Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Buy | M | 19.02 | 4,942 | 93,997 | 45,110 | 40.2 K to 45.1 K (+12.30 %) |
Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Sell | S | 119.51 | 12,558 | 1,500,807 | 40,168 | 52.7 K to 40.2 K (-23.82 %) |
Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Buy | M | 19.02 | 12,558 | 238,853 | 52,726 | 40.2 K to 52.7 K (+31.26 %) |
Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Option Exercise | M | 65.11 | 5,000 | 325,550 | 38,860 | |
Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 116.00 | 5,000 | 580,000 | 103,146 | 108.1 K to 103.1 K (-4.62 %) |
Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Buy | M | 65.11 | 5,000 | 325,550 | 108,146 | 103.1 K to 108.1 K (+4.85 %) |
Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | M | 19.02 | 17,500 | 332,850 | 0 | |
Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | M | 12.76 | 17,500 | 223,300 | 0 | |
Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Sell | S | 115.43 | 17,500 | 2,020,025 | 131,313 | 148.8 K to 131.3 K (-11.76 %) |
Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Buy | M | 12.76 | 17,500 | 223,300 | 148,813 | 131.3 K to 148.8 K (+13.33 %) |
Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Sell | S | 116.17 | 17,500 | 2,032,975 | 131,313 | 148.8 K to 131.3 K (-11.76 %) |
Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Buy | M | 19.02 | 17,500 | 332,850 | 148,813 | 131.3 K to 148.8 K (+13.33 %) |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 20,799 | 249,588 | 256,251 | |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 3,968 | 47,616 | 277,050 | |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 2,120 | 25,440 | 281,018 | |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 1,585 | 19,020 | 283,138 | |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 108.08 | 20,799 | 2,247,956 | 755,684 | 776.5 K to 755.7 K (-2.68 %) |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 20,799 | 249,588 | 776,483 | 755.7 K to 776.5 K (+2.75 %) |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 107.32 | 3,968 | 425,846 | 755,684 | 759.7 K to 755.7 K (-0.52 %) |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 3,968 | 47,616 | 759,652 | 755.7 K to 759.7 K (+0.53 %) |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 105.93 | 2,120 | 224,572 | 755,684 | 757.8 K to 755.7 K (-0.28 %) |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 2,120 | 25,440 | 757,804 | 755.7 K to 757.8 K (+0.28 %) |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 104.38 | 1,585 | 165,442 | 755,684 | 757.3 K to 755.7 K (-0.21 %) |
Nov 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 1,585 | 19,020 | 757,269 | 755.7 K to 757.3 K (+0.21 %) |
Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 14,420 | 173,040 | 284,723 | |
Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 13,352 | 160,224 | 299,143 | |
Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 700 | 8,400 | 312,495 | |
Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 82.01 | 14,420 | 1,182,584 | 755,684 | 770.1 K to 755.7 K (-1.87 %) |
Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 14,420 | 173,040 | 770,104 | 755.7 K to 770.1 K (+1.91 %) |
Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 82.89 | 13,352 | 1,106,747 | 755,684 | 769 K to 755.7 K (-1.74 %) |
Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 13,352 | 160,224 | 769,036 | 755.7 K to 769 K (+1.77 %) |
Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 83.90 | 700 | 58,730 | 755,684 | 756.4 K to 755.7 K (-0.09 %) |
Oct 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 700 | 8,400 | 756,384 | 755.7 K to 756.4 K (+0.09 %) |
Oct 03 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Option Exercise | M | 19.02 | 2,500 | 47,550 | 15,000 | |
Oct 03 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Option Exercise | M | 12.76 | 2,500 | 31,900 | 0 | |
Oct 03 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Sell | S | 84.85 | 2,500 | 212,125 | 48,013 | 50.5 K to 48 K (-4.95 %) |
Oct 03 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Buy | M | 12.76 | 2,500 | 31,900 | 50,513 | 48 K to 50.5 K (+5.21 %) |
Oct 03 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Sell | S | 85.33 | 2,500 | 213,325 | 48,013 | 50.5 K to 48 K (-4.95 %) |
Oct 03 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Buy | M | 19.02 | 2,500 | 47,550 | 50,513 | 48 K to 50.5 K (+5.21 %) |
Oct 02 2019 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Sell | S | 85.00 | 15,000 | 1,275,000 | 157,567 | 172.6 K to 157.6 K (-8.69 %) |
Oct 02 2019 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Sell | S | 85.00 | 3,716 | 315,860 | 70,688 | 74.4 K to 70.7 K (-4.99 %) |
Oct 02 2019 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Sell | S | 87.00 | 3,716 | 323,292 | 74,404 | 78.1 K to 74.4 K (-4.76 %) |
Sep 27 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 74.24 | 490 | 36,378 | 103,146 | 103.6 K to 103.1 K (-0.47 %) |
Sep 27 2019 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 73.72 | 2,510 | 185,037 | 103,636 | 106.1 K to 103.6 K (-2.36 %) |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 18,690 | 224,280 | 313,195 | |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 9,257 | 111,084 | 331,885 | |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 18,690 | 224,280 | 313,195 | |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 521 | 6,252 | 341,142 | |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 9,257 | 111,084 | 331,885 | |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 4 | 48 | 341,663 | |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 521 | 6,252 | 341,142 | |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.00 | 18,690 | 1,270,920 | 755,684 | 774.4 K to 755.7 K (-2.41 %) |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 4 | 48 | 341,663 | |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 18,690 | 224,280 | 774,374 | 755.7 K to 774.4 K (+2.47 %) |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.00 | 18,690 | 1,270,920 | 755,684 | 774.4 K to 755.7 K (-2.41 %) |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.91 | 9,257 | 637,900 | 755,684 | 764.9 K to 755.7 K (-1.21 %) |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 18,690 | 224,280 | 774,374 | 755.7 K to 774.4 K (+2.47 %) |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 9,257 | 111,084 | 764,941 | 755.7 K to 764.9 K (+1.22 %) |
Sep 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.91 | 9,257 | 637,900 | 755,684 | 764.9 K to 755.7 K (-1.21 %) |